David Nugent has increased his stake in Genedrive (LON: GDR) from 10.1% to 12.2%. The share price recovered 18.3% to 0.42p.
Following shareholder feedback Union Jack Oil (LON: UJO) has decided to offer bonus warrants to existing shareholders as well as the subscribers to the £2m fundraising at 5p/share. There will be one bonus warrant for every four shares held on 3 November. These warrants as well as the fundraise warrants are exercisable at 8p. The share price rose 5.15% to 5.1p.
AFC Energy (LON: AFC) says it has discussed the AGM resolution relating to the remuneration report with the largest shareholders. This is because, although it was passed, it only received 77.1% of votes. The board still believes that the remuneration report is in the best interests of the company. RBC Europe is no longer joint broker. The share price improved 2.02% to 9.855p.
FALLERS
WH Ireland (LON: WHI) shares have slipped a further 16.7% to 1.25p after it confirmed shareholders rejected the sale of the wealth management business and the proposed departure from AIM. Two non-executive directors are resigning from the board in January. There is sufficient capital to continue trading despite being loss making. Shareholders will be consulted about the future of the company.
Tavira Financial has exercised 18.75 million broker warrants in Kefi Minerals (LON: KEFI) at 0.6p/share. The share price slipped 14.6% to 1.23p.
Dekel Agri-Vision (LON: DKL) is building up cashew production and it has reached 500 tonnes/month, and additional equipment installations could increase that to up to 10,000 tonnes/month. Palm oil production fell 49% in the third quarter, although prices rose by 24%. The share price fell 14.3% to 0.45p.
Sareum Holdings (LON: SAR) has discontinued its 16-week GLP preclinical toxicology study for SDC-1801 following safety issues. The study was supposed to be a precursor to a phase 2 clinical development programme focused on psoriasis. However, the issues observed were predominantly in the control group, so it is unlikely it is due to SDC-1801 and Sareum plans to restart the study, and it can be completed within cash resources. The share price slipped 13.3% to 17.25p.
Premier Miton (LON: PMI) assets under management slipped from £10.5bn to £10.3bn in the quarter to September 2025. Annualised cost savings of £2m, have been identified. Full year results will be published on 4 December. The share price declined 5.56% to 59.5p.